Hif-2α mutated cancers Clinical Trials
Conditions / Hif-2α mutated cancers
Delta Trials tracks 1 clinical trial for Hif-2α mutated cancers in its publicly accessible dataset. Among the listed trials, 1 open for participant enrollment and 0 trials have reached completion. This research is carried out at 74 clinical sites around the world. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
1
Total Trials
1
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
74
Study Locations
Browse by location (74 total)
- Porto, Portugal 1 trialAll trials in Porto, Portugal
- München, Germany 1 trialAll trials in München, Germany
- Jongno-gu, South Korea 1 trialAll trials in Jongno-gu, South Korea
- Budapest, Hungary 1 trialAll trials in Budapest, Hungary
- Chicago, United States 1 trialAll trials in Chicago, United States
- Randwick, Australia 1 trialAll trials in Randwick, Australia
- Copenhagen, Denmark 1 trialAll trials in Copenhagen, Denmark
- Stockholm, Sweden 1 trialAll trials in Stockholm, Sweden
- Marseille, France 1 trialAll trials in Marseille, France
- Lisbon, Portugal 1 trialAll trials in Lisbon, Portugal
- Tokyo, Japan 1 trialAll trials in Tokyo, Japan
- Beijing, China 1 trialAll trials in Beijing, China
- Berlin, Germany 1 trialAll trials in Berlin, Germany
- Yüreğir, Turkey (türkiye) 1 trialAll trials in Yüreğir, Turkey (türkiye)
- Nankoku, Japan 1 trialAll trials in Nankoku, Japan
- Cambridge, United Kingdom 1 trialAll trials in Cambridge, United Kingdom
- Oslo, Norway 1 trialAll trials in Oslo, Norway
- St. Louis, United States 1 trialAll trials in St. Louis, United States
- Toronto, Canada 1 trialAll trials in Toronto, Canada
- Würzburg, Germany 1 trialAll trials in Würzburg, Germany